Molecular Partners AG

NasdaqGS:MOLN Stock Report

Market Cap: US$155.5m

Molecular Partners Future Growth

Future criteria checks 3/6

Molecular Partners's earnings are forecast to decline at 7% per annum while its annual revenue is expected to grow at 49.6% per year. EPS is expected to decline by 6.2% per annum. Return on equity is forecast to be 37.4% in 3 years.

Key information

-7.0%

Earnings growth rate

-6.2%

EPS growth rate

Biotechs earnings growth24.2%
Revenue growth rate49.6%
Future return on equity37.4%
Analyst coverage

Low

Last updated17 Mar 2025

Recent future growth updates

No updates

Recent updates

Molecular Partners: Leveraging Its Biologics Platform Into Early Clinical Programs

Jan 15

Molecular Partners: A Speculative Bet On Innovative DARPin Technology

Aug 07

Molecular Partners GAAP EPS of CHF4.59, revenue of CHF184.5M

Aug 25

Earnings and Revenue Growth Forecasts

NasdaqGS:MOLN - Analysts future estimates and past financials data (CHF Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202747-25-30522
12/31/202611-58-61-332
12/31/20251-59-63-553
12/31/20245-54-60-59N/A
9/30/20246-63-63-62N/A
6/30/20248-58-63-62N/A
3/31/20247-59-60-60N/A
12/31/20237-62-60-59N/A
9/30/20239-60-58-57N/A
6/30/20239-62-63-62N/A
3/31/202320-50-63-62N/A
12/31/2022190118117119N/A
9/30/2022189117112114N/A
6/30/2022190118111113N/A
3/31/2022182106101102N/A
12/31/202110-64-92-91N/A
9/30/20219-67-71-69N/A
6/30/20216-72-55-54N/A
3/31/20217-66-47-46N/A
12/31/20209-63-31-29N/A
9/30/202011-53-47-45N/A
6/30/202014-48-58-56N/A
3/31/202017-43-30-28N/A
12/31/201920-36-3-1N/A
9/30/201917-3701N/A
6/30/201914-3824N/A
3/31/201912-38-20-19N/A
12/31/201810-37-43-42N/A
9/30/201817-27N/A-41N/A
6/30/201823-18N/A-39N/A
3/31/201822-24N/AN/AN/A
12/31/201720-25N/A-40N/A
9/30/201717-26N/AN/AN/A
6/30/201716-28N/A-38N/A
3/31/201719-22N/AN/AN/A
12/31/201623-19N/A-35N/A
9/30/201627-13N/AN/AN/A
6/30/201631-3N/A18N/A
3/31/201630-2N/AN/AN/A
12/31/2015290N/A26N/A
9/30/201528-6N/AN/AN/A
6/30/201525-11N/A-24N/A
3/31/201526-5N/AN/AN/A
12/31/201427-2N/A-11N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: MOLN is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: MOLN is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: MOLN is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: MOLN's revenue (49.6% per year) is forecast to grow faster than the US market (8.4% per year).

High Growth Revenue: MOLN's revenue (49.6% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: MOLN's Return on Equity is forecast to be high in 3 years time (37.4%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/06 10:12
End of Day Share Price 2025/05/06 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Molecular Partners AG is covered by 10 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jo WaltonCredit Suisse
null nullCredit Suisse
Thomas KaufmannCredit Suisse